187 related articles for article (PubMed ID: 36958379)
1. A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk.
Rhee J; Barry KH; Huang WY; Sampson JN; Hofmann JN; Silverman DT; Calafat AM; Botelho JC; Kato K; Purdue MP; Berndt SI
Environ Res; 2023 Jul; 228():115718. PubMed ID: 36958379
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study.
Rhee J; Chang VC; Cheng I; Calafat AM; Botelho JC; Shearer JJ; Sampson JN; Setiawan VW; Wilkens LR; Silverman DT; Purdue MP; Hofmann JN
Environ Int; 2023 Oct; 180():108197. PubMed ID: 37741007
[TBL] [Abstract][Full Text] [Related]
3. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Chang VC; Rhee J; Berndt SI; Moore SC; Freedman ND; Jones RR; Silverman DT; Gierach GL; Hofmann JN; Purdue MP
Int J Cancer; 2023 Aug; 153(4):775-782. PubMed ID: 36843273
[TBL] [Abstract][Full Text] [Related]
4. A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen.
Purdue MP; Rhee J; Denic-Roberts H; McGlynn KA; Byrne C; Sampson J; Botelho JC; Calafat AM; Rusiecki J
Environ Health Perspect; 2023 Jul; 131(7):77007. PubMed ID: 37458713
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
[TBL] [Abstract][Full Text] [Related]
6. Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma.
Shearer JJ; Callahan CL; Calafat AM; Huang WY; Jones RR; Sabbisetti VS; Freedman ND; Sampson JN; Silverman DT; Purdue MP; Hofmann JN
J Natl Cancer Inst; 2021 May; 113(5):580-587. PubMed ID: 32944748
[TBL] [Abstract][Full Text] [Related]
7. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study.
Wen X; Wang M; Xu X; Li T
Environ Health Perspect; 2022 Jun; 130(6):67007. PubMed ID: 35731224
[TBL] [Abstract][Full Text] [Related]
8. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
[TBL] [Abstract][Full Text] [Related]
9. Serum vaccine antibody concentrations in adults exposed to per- and polyfluoroalkyl substances: A birth cohort in the Faroe Islands.
Shih YH; Blomberg AJ; Bind MA; Holm D; Nielsen F; Heilmann C; Weihe P; Grandjean P
J Immunotoxicol; 2021 Dec; 18(1):85-92. PubMed ID: 34143710
[TBL] [Abstract][Full Text] [Related]
10. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability.
Lyall K; Yau VM; Hansen R; Kharrazi M; Yoshida CK; Calafat AM; Windham G; Croen LA
Environ Health Perspect; 2018 Jan; 126(1):017001. PubMed ID: 29298162
[TBL] [Abstract][Full Text] [Related]
12. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
[TBL] [Abstract][Full Text] [Related]
13. Profiles of Emerging and Legacy Per-/Polyfluoroalkyl Substances in Matched Serum and Semen Samples: New Implications for Human Semen Quality.
Pan Y; Cui Q; Wang J; Sheng N; Jing J; Yao B; Dai J
Environ Health Perspect; 2019 Dec; 127(12):127005. PubMed ID: 31841032
[TBL] [Abstract][Full Text] [Related]
14. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.
Calafat AM; Kato K; Hubbard K; Jia T; Botelho JC; Wong LY
Environ Int; 2019 Oct; 131():105048. PubMed ID: 31376596
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
16. Assessing exposures to per- and polyfluoroalkyl substances in two populations of Great Lakes Basin fish consumers in Western New York State.
Liu M; Nordstrom M; Forand S; Lewis-Michl E; Wattigney WA; Kannan K; Wang W; Irvin-Barnwell E; Hwang SA
Int J Hyg Environ Health; 2022 Mar; 240():113902. PubMed ID: 34915281
[TBL] [Abstract][Full Text] [Related]
17. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
18. Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk.
van Gerwen M; Colicino E; Guan H; Dolios G; Nadkarni GN; Vermeulen RCH; Wolff MS; Arora M; Genden EM; Petrick LM
EBioMedicine; 2023 Nov; 97():104831. PubMed ID: 37884429
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
